about
Magnetization transfer in lamellar liquid crystalsEffectiveness of anti-TNFα for Crohn disease: research in a pediatric learning health system.Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycan-polysaccharide rat model of Crohn's disease.Increasing hospitalizations in inflammatory bowel disease among children in the United States, 1988-2011.CT enterography of pediatric Crohn disease.The prognostic power of the NOD2 genotype for complicated Crohn's disease: a meta-analysis.MRI diffusion-weighted imaging (DWI) in pediatric small bowel Crohn disease: correlation with MRI findings of active bowel wall inflammation.Effects of inflammatory bowel disease on students' adjustment to college.Transanal delivery of angiotensin converting enzyme inhibitor prevents colonic fibrosis in a mouse colitis model: development of a unique mode of treatment.Anti-tumor necrosis factor α prevents bowel fibrosis assessed by messenger RNA, histology, and magnetization transfer MRI in rats with Crohn's disease.Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn's disease.Development of a peptidoglycan-polysaccharide murine model of Crohn's disease: effect of genetic background.What Role Do Immunomodulators Have in Assessing Response to Curcumin as an Add-on Therapy for Patients With Ulcerative Colitis?Comparison of MR enterography and histopathology in the evaluation of pediatric Crohn diseaseGetting the steak without the sizzle: is MR enterography as good as CT enterography?Letter: rapid infliximab infusion is not always safe--authors' replyVariation in infliximab administration practices in the treatment of pediatric inflammatory bowel diseaseIdentifying perianal fistula complications in pediatric patients with Crohn's disease using administrative claimsFactors Associated With Development of Perianal Fistulas in Pediatric Patients With Crohn's Disease
P50
Q30698408-C6482924-2FB4-43E1-8A72-C553523FDFB4Q35935859-53E81BEE-8BEC-45E9-997D-A90C4EBC89BCQ36206802-0F774144-BC6A-41A1-84A4-AED1C8BEDB33Q36602703-447F2EC6-A066-4CF4-8D90-AF1DC8093E28Q37638339-7E2AE1B9-D757-42FE-85E3-FC0ACAFC9FE2Q37846097-9C92BD88-F512-4157-B3F3-785EA11C4562Q38129339-CECBAAA3-6D1C-424C-B090-1F3E37FBC2F0Q39210949-F3004DD0-4ACC-4EBE-9770-6976B7C3057EQ41814503-73D13B9D-51BB-4E69-9C6E-3AF640D50BF8Q44132897-BAF2F295-18BF-4C2D-BF7E-C1F776C4F923Q46227060-B0DA8EB7-4B66-4432-AF2B-480A283C8897Q51039914-03B851D8-1242-48E6-B95F-065128486DEBQ55059315-C8071638-4576-46F4-959F-F842E693DF50Q57119268-6F14DEDE-0F6E-4506-87C7-0CFD3B1EF0C0Q84512076-15574E49-A44F-40CE-84DB-BBD5B7BB3A0CQ85194766-51A1912C-ECB1-45D4-AD44-4F4B8F57B404Q86267358-F4A50A16-FA9D-401E-AB09-B58C63BB3A84Q92616601-A1AFA506-9D75-4126-9070-C7BFCED10271Q94493024-F659FAA7-50C1-435F-9F00-61C022470DED
P50
description
researcher ORCID ID = 0000-0002-4857-6098
@en
name
Jeremy Adler
@ast
Jeremy Adler
@en
Jeremy Adler
@es
Jeremy Adler
@nl
type
label
Jeremy Adler
@ast
Jeremy Adler
@en
Jeremy Adler
@es
Jeremy Adler
@nl
prefLabel
Jeremy Adler
@ast
Jeremy Adler
@en
Jeremy Adler
@es
Jeremy Adler
@nl
P31
P496
0000-0002-4857-6098